Organisation paid for research Program year 2025 Source: CMS Open Payments

Sheldon Freedman MD Ltd

Neither a doctor nor a teaching hospital

Research payments

$477,144

68 payments

Through program year 2025, Sheldon Freedman MD Ltd is reported as receiving $477,144 in research payments, across 68 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$359,072	28
2024	Research	$6,941	4
2023	Research	$25,615	7
2022	Research	$32,759	18
2021	Research	$2,599	1
2019	Research	$50,158	10

Breakdown

Who paid Research payments · program years 2019–2025

Laborie Medical Technologies Corp. $359,072 28 payments
AbbVie, Inc. $90,976 27 payments
Urovant Sciences Inc $24,143 9 payments
Sumitomo Pharma America, Inc. $2,953 4 payments

Studies the money was for Research payments · program years 2019–2025

Peak $329,869 15 payments
M16-100 $50,158 10 payments
Pinnacle $20,750 9 payments
A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) $18,943 6 payments
Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) $17,864 4 payments
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men $11,796 10 payments
Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitisx2FBladder Pain Syndrome (ICx2FBPS) $6,500 1 payment
A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) $6,062 4 payments
Apex $4,753 3 payments
Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis;Bladder Pain Syndrome $4,631 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.